Active — Not RecruitingPhase 1

Safety of ENC-201-CED ENCRT

Canada10 participantsStarted 2024-05-01

Plain-language summary

The purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Candidates must satisfy site's eligibility for standard of care islet infusion. Exclusion Criteria: * Candidates are excluded based on the site's criteria for standard of care islet infusion.

What they're measuring

Safety

Timeframe: Day 1 through Day 134

Trial details

NCT IDNCT06408311

SponsorEncellin

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-07-31

View on ClinicalTrials.gov More Diabetes Mellitus, Type 1 trials